{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:56:20Z","timestamp":1785531380789,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100011893","name":"Pan American Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jval.2025.06.012","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:04:17Z","timestamp":1751853857000},"page":"1497-1505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics"],"prefix":"10.1016","volume":"28","author":[{"given":"Luis","family":"Michea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumava","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Jami","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ordunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliana","family":"Kostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Rosende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.jval.2025.06.012_bib1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"9932","key":"10.1016\/j.jval.2025.06.012_bib2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jval.2025.06.012_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jval.2025.06.012_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007571","article-title":"The correlation between blood pressure and kidney function decline in older people: a registry-based cohort study","volume":"5","author":"Vaes","year":"2015","journal-title":"BMJ Open"},{"issue":"21","key":"10.1016\/j.jval.2025.06.012_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.5119","article-title":"Global deaths attributable to high systolic blood pressure, 1990-2016","volume":"319","author":"Marczak","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2025.06.012_bib7","author":"Aguilera"},{"key":"10.1016\/j.jval.2025.06.012_bib8","author":"Herrera"},{"issue":"1","key":"10.1016\/j.jval.2025.06.012_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1514202","article-title":"Innovation and change in the Chilean health system","volume":"374","author":"Bossert","year":"2016","journal-title":"N Engl J Med"},{"issue":"10304","key":"10.1016\/j.jval.2025.06.012_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2025.06.012_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100044","article-title":"Prevalence and control rates of hypertension in the USA: 2017-2018","volume":"6","author":"Chobufo","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"issue":"23","key":"10.1016\/j.jval.2025.06.012_bib12","doi-asserted-by":"crossref","first-page":"E854","DOI":"10.1503\/cmaj.210140","article-title":"Refocusing on hypertension control in Canada","volume":"193","author":"Leung","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.jval.2025.06.012_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/2150132720924884","article-title":"National health policy reform for primary care in Chile: a qualitative analysis of the health program documents","volume":"11","author":"Dominguez-Cancino","year":"2020","journal-title":"J Prim Care Community Health"},{"issue":"12","key":"10.1016\/j.jval.2025.06.012_bib15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/jch.12861","article-title":"Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: the standardized hypertension treatment and prevention project","volume":"18","author":"Patel","year":"2016","journal-title":"J Clin Hypertens"},{"issue":"6","key":"10.1016\/j.jval.2025.06.012_bib16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/jch.13307","article-title":"Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League","volume":"20","author":"Campbell","year":"2018","journal-title":"J Clin Hypertens"},{"issue":"1","key":"10.1016\/j.jval.2025.06.012_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1471-2458-9-355","article-title":"A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem","volume":"9","author":"Maher","year":"2009","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.jval.2025.06.012_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jch.12803","article-title":"The Kaiser Permanente Northern California story: improving hypertension control from 44% to 90% in 13 years (2000 to 2013)","volume":"18","author":"Jaffe","year":"2016","journal-title":"J Clin Hypertens"},{"issue":"7","key":"10.1016\/j.jval.2025.06.012_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2013.108769","article-title":"Improved blood pressure control associated with a large-scale hypertension program","volume":"310","author":"Jaffe","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jval.2025.06.012_bib20","first-page":"544","article-title":"Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience","volume":"30","author":"Sim","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jval.2025.06.012_bib21","volume":"46","author":"Michea","year":"2022","journal-title":"Rev Pan Am Salud Publ Pan Am J Public Health"},{"issue":"4","key":"10.1016\/j.jval.2025.06.012_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071036","article-title":"Scaling hypertension treatment in 24 low-income and middle-income countries: economic evaluation of treatment decisions at three blood pressure cut-points","volume":"14","author":"Hutchinson","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jval.2025.06.012_bib24","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"7","author":"Husereau","year":"2022","journal-title":"MDM Policy Pract"},{"issue":"1","key":"10.1016\/j.jval.2025.06.012_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1091142119890369","article-title":"Social discount rates for seventeen Latin American countries: theory and parameter estimation","volume":"48","author":"Moore","year":"2020","journal-title":"Public Fin Rev"},{"key":"10.1016\/j.jval.2025.06.012_bib26","article-title":"Hearts: technical package for cardiovascular disease management in primary health care","year":"2016","journal-title":"World Health Organization"},{"issue":"6","key":"10.1016\/j.jval.2025.06.012_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061467","article-title":"Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application","volume":"12","author":"Husain","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jval.2025.06.012_bib29","article-title":"Assessing costs of a hypertension program in primary care: evidence from the HEARTS program in Mexico","volume":"46","author":"Chivardi","year":"2023","journal-title":"Rev Panam Salud Publ"},{"issue":"3","key":"10.1016\/j.jval.2025.06.012_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jval.2025.06.012_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2015.03.517","article-title":"The who-choice cost-effectiveness threshold: a country-level analysis of changes over time","volume":"18","author":"Griffiths","year":"2015","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2025.06.012_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jval.2017.12.016","article-title":"Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: trends in cost-per-DALY studies","volume":"21","author":"Leech","year":"2018","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2025.06.012_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jval.2021.08.014","article-title":"The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review","volume":"25","author":"Kazibwe","year":"2022","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.jval.2025.06.012_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168512","article-title":"A systematic review of cost-effectiveness studies reporting cost-per-DALY averted","volume":"11","author":"Neumann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2025.06.012_bib35","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.2147\/PPA.S368784","article-title":"A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider","volume":"16","author":"Hamrahian","year":"2022","journal-title":"Patient Prefer Adherence"},{"issue":"10022","key":"10.1016\/j.jval.2025.06.012_bib36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2025.06.012_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2021.100068","article-title":"Impact of common cardio-metabolic risk factors on fatal and non-fatal cardiovascular disease in Latin America and the Caribbean: an individual-level pooled analysis of 31 cohort studies","author":"Carrillo-Larco","year":"2021","journal-title":"The Lancet Regional Health"},{"issue":"12","key":"10.1016\/j.jval.2025.06.012_bib38","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.jval.2025.06.012_bib39","series-title":"Global Burden of Disease Study 2019 (GBD 2019) Disability Weights","year":"2024"},{"issue":"1","key":"10.1016\/j.jval.2025.06.012_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1472-6963-9-85","article-title":"Methods for economic evaluation of a factorial-design cluster randomised controlled trial of a nutrition supplement and an exercise programme among healthy older people living in Santiago, Chile: the CENEX study","volume":"9","author":"Walker","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.jval.2025.06.012_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s41669-021-00282-7","article-title":"A model-based economic evaluation of cladribine versus alemtuzumab, ocrelizumab and natalizumab for the treatment of relapsing-remitting multiple sclerosis with high disease activity in Chile","volume":"5","author":"Espinoza","year":"2021","journal-title":"Pharmacoecon Open"},{"issue":"2","key":"10.1016\/j.jval.2025.06.012_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1753944709356012","article-title":"Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy","volume":"4","author":"Basile","year":"2010","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.jval.2025.06.012_bib43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2025.06.012_bib44","article-title":"Chile\u2019s public healthcare sector hypertension control rates before and during the pandemic and HEARTS implementation","volume":"46","author":"Barake","year":"2023","journal-title":"Rev Panam Salud Publ"},{"issue":"4","key":"10.1016\/j.jval.2025.06.012_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11906-023-01286-w","article-title":"HEARTS in the Americas: targeting health system change to improve population hypertension control","volume":"26","author":"Ordunez","year":"2024","journal-title":"Curr Hypertens Rep"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525024271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525024271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:26:13Z","timestamp":1773455173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525024271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1098301525024271"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.06.012","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}